The penetrance of the disease varies widely depending on the MMR gene affected in the germline, with MLH1 and MSH2 genes being associated with relatively high cancer risk (about 50%: Prospective Lynch Syndrome Database or PLSD) (83) and found in about 90% of LS-associated tumors. This evidence concerns the gene MSH2 and cancer.